HARNESS THERAPEUTICS LIMITED
Company number 11532498 · Monitor this company
Free AI analysis
Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.
Overview
- Company type
- Private Limited Company
- Incorporated
- 2018-08-22
- Registered office
- Minerva Building (B250) Babraham Research Campus, Cambridge, United Kingdom, CB22 3AT
- Postcode
- CB22 3AT
- Capital
- 1 GBP
- Accounts category
- Small
Accounts
- Last made up to
- 2025-12-31
- Next due by
- 2027-09-30
- Financial year end
- 31 December
Confirmation statement
- Last statement dated
- 2025-08-21
- Next due by
- 2026-09-04
Nature of business (SIC)
- 72110 Research and experimental development on biotechnology
Officers 5 current · 10 resigned
Group structure
Controlled by DEMENTIA DISCOVERY GP LP — since 2023-11-16
Controlled by Takeda Pharmaceutical Company Limited (1200-01-077461) — since 2020-01-28
From persons-with-significant-control filings on the public register.
Licensed visa sponsor
Licensed by the Home Office to sponsor worker visas: Skilled Worker (Worker (A rating)).
Matched by registered name to the register of licensed sponsors (Home Office, updated daily) — check the register itself before relying on it. Contains public sector information licensed under the Open Government Licence v3.0.
Previous company names
| Name | Date changed |
|---|---|
| TRANSINE THERAPEUTICS LIMITED | 2024-01-22 |
Previous registered addresses 1
| Address | Changed on |
|---|---|
| 1 MIDDLE DRIFT, ROYSTON, SG8 5BU, UNITED KINGDOM | 2019-09-13 |
The class of 2018
36%
of the 439 companies in this sector incorporated in 2018 are still active today; 60% have since been dissolved.
A fact about the year, not a forecast for this company.